IQVIA HOLDINGS INC. (IQV) Latest Company News

Sep 15, 2026, 13:00 UTC
The Trade Desk announced expanded healthcare measurement and optimization integrations with Veeva Crossix and IQVIA Digital for pharmaceutical advertisers.
Source:
- businesswire.com
- zacks.com
Sep 15, 2026, 12:07 UTC
LB Pharmaceuticals Inc appointed Susan G. Kozauer, M.D. as Chief Medical Officer effective September 14, 2026.
Sep 9, 2026, 12:17 UTC
IQVIA plans to issue $2 billion in senior notes due 2034.
Source:
- finance.sina.cn
Aug 21, 2026, 19:51 UTC
Iqvia Holdings Inc. stock reached a 52-week high of $260.32, reflecting a 38% gain over the past year and a 54.6% surge over the past six months.
Source:
- investing.com
- investing.com
Aug 20, 2026, 07:24 UTC
BlackRock Inc. acquired a new position in IQVIA Holdings Inc., buying 14,549,693 shares valued at approximately $2.81 billion, representing about 8.84% ownership, as disclosed in a 13F filing.
Source:
- defenseworld.net
Jul 28, 2026, 11:11 UTC
IQVIA Holdings reported its Q2 FY2026 (April-June) financial results, with revenue up 8.7% year-over-year to $4.368 billion, operating income flat at $506 million, and diluted EPS of $1.53.
Source:
Jul 27, 2026, 04:35 UTC
IQVIA promoted Roy Rohan Richard to director of talent acquisition.
Source:
- hrkatha.com
Jun 11, 2026, 00:00 UTC
IQVIA Holdings Inc. issued €950 million aggregate principal amount of 4.625% senior unsecured notes due 2033, with net proceeds to refinance existing indebtedness and pay offering-related fees and expenses.
Jun 4, 2026, 14:51 UTC
IQVIA Inc., a wholly owned subsidiary of IQVIA Holdings Inc., priced an offering of €950 million in senior notes due 2033 to refinance existing indebtedness.

IQV

The Trade Desk announced expanded healthcare measurement and optimization integrations with Veeva Crossix and IQVIA Digital for pharmaceutical advertisers.

LB Pharmaceuticals Inc appointed Susan G. Kozauer, M.D. as Chief Medical Officer effective September 14, 2026.

IQVIA plans to issue $2 billion in senior notes due 2034.

Iqvia Holdings Inc. stock reached a 52-week high of $260.32, reflecting a 38% gain over the past year and a 54.6% surge over the past six months.

BlackRock Inc. acquired a new position in IQVIA Holdings Inc., buying 14,549,693 shares valued at approximately $2.81 billion, representing about 8.84% ownership, as disclosed in a 13F filing.

IQVIA Holdings reported its Q2 FY2026 (April-June) financial results, with revenue up 8.7% year-over-year to $4.368 billion, operating income flat at $506 million, and diluted EPS of $1.53.

IQVIA promoted Roy Rohan Richard to director of talent acquisition.

IQVIA Holdings Inc. issued €950 million aggregate principal amount of 4.625% senior unsecured notes due 2033, with net proceeds to refinance existing indebtedness and pay offering-related fees and expenses.

IQVIA Inc., a wholly owned subsidiary of IQVIA Holdings Inc., priced an offering of €950 million in senior notes due 2033 to refinance existing indebtedness.